Obesity has become a global health challenge and associated with several comorbidities that include: certain cancers, dyslipidemia, cardiovascular morbidity, type 2 diabetes and reduced overall quality of life.
Weight loss is recommended for type 2 diabetics as it can improve glycemic control and other risk factors.
Patients with type 2 diabetes usually have a reduced response to weight loss.
Saxenda (liraglutide) has become a popular aid for diabetes patients looking to lose weight. In simple terms, Saxenda makes you feel full after you eat. By eating less, patients have resulted in rapid weight loss.